Daniel Corum

Daniel Corum has a diverse work experience in the field of oncology and pharmaceuticals. Daniel currently holds the position of Executive Director, Clinical Development at Kura Oncology Inc. starting in June 2023. Prior to this, they worked as a Senior Director, Clinical Development at the same company from June 2022 to June 2023.

Before joining Kura Oncology, Daniel served as a Senior Director, Clinical Development at Istari Oncology from July 2020 to June 2022. Daniel also worked as a Clinical Development Consultant in the field of oncology at Biotech - Oncology from April 2019 to July 2020.

In addition, Daniel has experience as an Associate Director of Medical and Scientific Affairs at Innocrin Pharmaceuticals Inc. from September 2017 to January 2019. Daniel also co-founded Endurowerks and held the position of Co-Founder from August 2014 to September 2018.

Daniel's experience also includes working as a Medical Liaison at Eli Lilly and Company from April 2016 to April 2017. Daniel worked as a Postdoctoral Fellow at MUSC College of Pharmacy - Department of Drug Discovery and Biomedical Sciences from August 2014 to October 2015. Daniel started their career as a Laboratory Technician at US EPA National Center for Computational Toxicology from January 2008 to July 2009.

From 2009 to 2014, Daniel Corum attended the Medical University of South Carolina, where they obtained a Doctor of Philosophy (Ph.D.) degree in Cellular and Molecular Biology with a focus on Cancer biology.